Identification of Biomarkers for Early Detection of Pancreatic Cancer
Completed
Conditions studied: Pancreatic Cancer
In brief
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is examining blood samples from patients with cancer to identify biomarkers that may help in the early detection of pancreatic cancer.
Key facts
- Study ID
- NCT00897494
- Run by
- Barbara Ann Karmanos Cancer Institute
- People needed
- 75
- Starts
- 2005-02-01
- Expected to finish
- 2011-04-01
- Last updated by the study team
- 2016-03-09
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.